|
Lymphoid Neoplasia
Citations 31-40 of 299 total displayed.
|
Past content
(since Jan 2009):
|
Eµ-BCL10 mice exhibit constitutive activation of both canonical and noncanonical NF- B pathways generating marginal zone (MZ) B-cell expansion as a precursor to splenic MZ lymphoma
- Zhaoyang Li, Hongsheng Wang, Liquan Xue, Dong-Mi Shin, Derry Roopenian, Wu Xu, Chen-Feng Qi, Mark Y. Sangster, Carlos J. Orihuela, Elaine Tuomanen, Jerold E. Rehg, Xiaoli Cui, Quangeng Zhang, Herbert C. Morse, III, and Stephan W. Morris
Blood 2009; 114: 4158-4168.
[Abstract]
[Full text]
[PDF]
miR-128b is a potent glucocorticoid sensitizer in MLL-AF4 acute lymphocytic leukemia cells and exerts cooperative effects with miR-221
- Ai Kotani, Daon Ha, James Hsieh, Prakash K. Rao, Diana Schotte, Monique L. den Boer, Scott A. Armstrong, and Harvey F. Lodish
Blood 2009; 114: 4169-4178.
[Abstract]
[Full text]
[PDF]
Aberrant splicing of the E-cadherin transcript is a novel mechanism of gene silencing in chronic lymphocytic leukemia cells
- Sanjai Sharma and Alan Lichtenstein
Blood 2009; 114: 4179-4185.
[Abstract]
[Full text]
[PDF]
Outcome of congenital acute lymphoblastic leukemia treated on the Interfant-99 protocol
- Marieke H. van der Linden, Maria Grazia Valsecchi, Paola De Lorenzo, Anja Möricke, Gritta Janka, Thierry M. Leblanc, Maria Felice, Andrea Biondi, Myriam Campbell, Ian Hann, Jeffrey E. Rubnitz, Jan Stary, Tomasz Szczepanski, Ajay Vora, Alina Ferster, Liisa Hovi, Lewis B. Silverman, and Rob Pieters
Blood 2009; 114: 3764-3768.
[Abstract]
[Full text]
[PDF]
Kinetics of normal hematopoietic stem and progenitor cells in a Notch1-induced leukemia model
- Xiaoxia Hu, Hongmei Shen, Chen Tian, Hui Yu, Guoguang Zheng, Richard XuFeng, Zhenyu Ju, Jing Xu, Jianmin Wang, and Tao Cheng
Blood 2009; 114: 3783-3792.
[Abstract]
[Full text]
[PDF]
CD20-targeted tetrameric interferon- , a novel and potent immunocytokine for the therapy of B-cell lymphomas
- Edmund A. Rossi, David M. Goldenberg, Thomas M. Cardillo, Rhona Stein, and Chien-Hsing Chang
Blood 2009; 114: 3864-3871.
[Abstract]
[Full text]
[PDF]
Karyotype-specific microRNA signature in chronic lymphocytic leukemia
- Rosa Visone, Laura Z. Rassenti, Angelo Veronese, Cristian Taccioli, Stefan Costinean, Baltazar D. Aguda, Stefano Volinia, Manuela Ferracin, Jeff Palatini, Veronica Balatti, Hansjuerg Alder, Massimo Negrini, Thomas J. Kipps, and Carlo M. Croce
Blood 2009; 114: 3872-3879.
[Abstract]
[Full text]
[PDF]
Myeloma cell line–derived, pooled heat shock proteins as a universal vaccine for immunotherapy of multiple myeloma
- Jianfei Qian, Sungyoul Hong, Siqing Wang, Liang Zhang, Luhong Sun, Michael Wang, Jing Yang, Larry W. Kwak, Jian Hou, and Qing Yi
Blood 2009; 114: 3880-3889.
[Abstract]
[Full text]
[PDF]
C/EBPβ regulates transcription factors critical for proliferation and survival of multiple myeloma cells
- Rekha Pal, Martin Janz, Deborah L. Galson, Margarete Gries, Shirong Li, Korinna Jöhrens, Ioannis Anagnostopoulos, Bernd Dörken, Markus Y. Mapara, Lisa Borghesi, Lela Kardava, G. David Roodman, Christine Milcarek, and Suzanne Lentzsch
Blood 2009; 114: 3890-3898.
[Abstract]
[Full text]
[PDF]
MYC gene rearrangements are associated with a poor prognosis in diffuse large B-cell lymphoma patients treated with R-CHOP chemotherapy
- Kerry J. Savage, Nathalie A. Johnson, Susana Ben-Neriah, Joseph M. Connors, Laurie H. Sehn, Pedro Farinha, Douglas E. Horsman, and Randy D. Gascoyne
Blood 2009; 114: 3533-3537.
[Abstract]
[Full text]
[PDF]
|
|
